T. Rowe Price Investment Management, Inc.

Position in IMCR — Immunocore Holdings plc

CIK 1897612 BALTIMORE, MD

Position in IMCR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$57,031,740

-$149,882,449 QoQ

Shares Held

1,891,600

-68.3% QoQ

Ownership

3.72%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

T. Rowe Price Investment Management, Inc. holds $11,176,949,825 across 48 Biotechnology names. IMCR ranks #26 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	5,193,324	$1,718,315,111
2	ASND	Ascendis Pharma A/S	6,162,042	$1,409,443,866
3	CYTK	Cytokinetics Inc	17,523,840	$1,154,996,294
4	APGE	Apogee Therapeutics, Inc.	10,300,984	$867,033,823
5	PCVX	Vaxcyte, Inc.	12,126,017	$704,642,847
6	DYN	Dyne Therapeutics, Inc.	30,785,801	$558,146,572
7	BNTX	BioNTech SE	5,856,073	$520,487,768
8	IONS	Ionis Pharmaceuticals Inc	6,159,027	$462,481,337

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$57,031,740	1,891,600	-37.8%	Shares	Sole	2026-05-15
2026-02-28	$98,253,499	3,041,904	-49.0%	Shares	Sole	2026-03-06
2025-12-31	$206,914,189	5,961,227	-15.6%	Shares	Sole	2026-02-19
2025-09-30	$256,631,341	7,063,896	-0.1%	Shares	Sole	2025-11-14
2025-06-30	$221,783,139	7,067,659	+0.2%	Shares	Sole	2025-08-14
2025-03-31	$209,227,440	7,051,818	+5.2%	Shares	Sole	2025-05-14
2024-12-31	$197,656,136	6,700,208	+3.1%	Shares	Sole	2025-02-14
2024-09-30	$202,339,863	6,499,835	+117.2%	Shares	Sole	2024-11-14
2024-06-30	$101,408,131	2,992,273	+307.9%	Shares	Sole	2024-08-14
2024-03-31	$47,684,715	733,611	+95.9%	Shares	Sole	2024-05-15
2023-12-31	$25,590,007	374,561	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.